Ultrasound contrast agents can transform the role of ultrasound, allowing clinicians to study the enhancement patterns of liver lesions in real time, providing faster and more definitive diagnoses.
With Philips ultrasound, contrast enhanced ultrasound is seamlessly integrated into the standard workflow, providing exceptional detail throughout arterial, portal, and late phase scanning. Additionally, with advanced technologies such as MaxVue, PureWave C9-2 transducer, fusion Imaging and integrated quantification via Philips Q-Apps, maximum confidence and the ultimate liver solution becomes a reality even in the most challenging exams. Innovative solutions such as xMatrix 3D/4D technology can also transform the assessment of lesions in the liver, providing a fast and effective way to visualize feeding vessels and response to treatment. There are many exciting developments in the field of CEUS, click on the link to contact your local Philips representative.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.